BIOMAT Database Logo BIOMAT Database Logo

[The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)]. 1974

E Haupt, and J Beyer, and K Schöffling

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin

Related Publications

E Haupt, and J Beyer, and K Schöffling
Effect of weight reduction on the glucose tolerance in obese maturity onset diabetics.
January 1977, The Journal of the Egyptian Public Health Association,
E Haupt, and J Beyer, and K Schöffling
[Diurnal variation in glucose tolerance in maturity onset diabetics and normal subjects with respect to gastric emptying (author's transl)].
December 1979, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
E Haupt, and J Beyer, and K Schöffling
Glucose tolerance tests in 727 first-degree relatives of maturity-onset diabetics.
June 1969, German medical monthly,
E Haupt, and J Beyer, and K Schöffling
[Glisoxepide treatment in maturity-onset diabetics (author's transl)].
November 1976, Deutsche medizinische Wochenschrift (1946),
E Haupt, and J Beyer, and K Schöffling
[Influence of obesity and maturity-onset diabetes on the kinetics of NEFA during oral glucose tolerance tests (OGTT)].
July 1979, Giornale di clinica medica,
E Haupt, and J Beyer, and K Schöffling
[Flat curves of oral glucose tolerance tests (author's transl)].
April 1980, La Nouvelle presse medicale,
E Haupt, and J Beyer, and K Schöffling
[Effect of benfluorex on the metabolic fate of an oral glucose load in obese subjects with reduced glucose tolerance (author's transl)].
January 1979, Therapie,
E Haupt, and J Beyer, and K Schöffling
The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
May 1977, The Journal of clinical endocrinology and metabolism,
E Haupt, and J Beyer, and K Schöffling
[The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].
April 1980, Wiener klinische Wochenschrift,
E Haupt, and J Beyer, and K Schöffling
Lack of effect of propranolol and metoprolol on glucose tolerance in maturity-onset diabetics.
November 1980, British medical journal,
Copied contents to your clipboard!